Palupi 1997

Methods	RCT Length of follow‐up: 9 weeks (2.25 months)
Participants	All children living in endemic area Number analysed for primary outcome: 191 Age range: 2 to 5 years Inclusion criteria: children ages 2 to 5 years registered at village health centres Exclusion criteria: none stated
Interventions	Single dose vs placebo Albendazole: 400 mg plus 30 mg elemental iron weekly; Elemental iron: 30 mg weekly.
Outcomes	Mean change in weight post‐treatment; Mean change in height post‐treatment; Mean change in haemoglobin post‐treatment; Mean haemoglobin post‐treatment. Not included in review: z‐scores for height‐for‐age, weight‐for‐age, and weight‐for‐height (NCHS reference)
Notes	Location: Java, Indonesia Community category: 2 Source of funding: Kimia Farma Indonesia.
Risk of bias
Bias	Authors' judgement	Support for judgement
Random sequence generation (selection bias)	Unclear risk	"The children were randomly divided into three, equal‐sized treatment groups". No further details reported.
Allocation concealment (selection bias)	Unclear risk	No details reported.
Blinding (performance bias and detection bias) All outcomes	Unclear risk	Described as double blind. Participants were blinded, unclear whether provider and assessor were blinded.
Incomplete outcome data (attrition bias) All outcomes	Low risk	97% (289/299) of enrolled participants were evaluated. Inclusion of all randomized participants (number evaluable/number randomized): 97% (289/299).
Selective reporting (reporting bias)	Low risk	Pre‐specfied outcomes reported.
Other bias	Low risk	No obvious other source of bias.